ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,125.65
0.87%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sana Biotechnology Inc (SANA)

  7. Sana Biotechnology Inc (SANA) News

Sana Biotechnology (SANA)

Sana Biotechnology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SANA
DateTimeSourceHeadlineSymbolCompany
21/05/202414:00GlobeNewswire Inc.Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other GliaNASDAQ:SANASana Biotechnology Inc
08/05/202421:49Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SANASana Biotechnology Inc
08/05/202421:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SANASana Biotechnology Inc
08/05/202421:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
08/05/202421:05GlobeNewswire Inc.Sana Biotechnology Reports First Quarter 2024 Financial Results and Business UpdatesNASDAQ:SANASana Biotechnology Inc
06/05/202421:05GlobeNewswire Inc.Sana Biotechnology to Present at May and June 2024 Investor ConferencesNASDAQ:SANASana Biotechnology Inc
08/03/202421:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SANASana Biotechnology Inc
08/03/202421:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SANASana Biotechnology Inc
29/02/202421:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
29/02/202421:05GlobeNewswire Inc.Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business UpdatesNASDAQ:SANASana Biotechnology Inc
28/02/202421:05GlobeNewswire Inc.Sana Biotechnology to Present at the Cowen 44th Annual Health Care ConferenceNASDAQ:SANASana Biotechnology Inc
14/02/202421:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SANASana Biotechnology Inc
13/02/202421:05GlobeNewswire Inc.Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHPNASDAQ:SANASana Biotechnology Inc
12/02/202421:05GlobeNewswire Inc.Sana Biotechnology Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:SANASana Biotechnology Inc
08/02/202422:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
08/02/202421:49Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SANASana Biotechnology Inc
08/02/202406:22GlobeNewswire Inc.Sana Biotechnology Announces Pricing of Upsized Public OfferingNASDAQ:SANASana Biotechnology Inc
08/02/202402:59Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:SANASana Biotechnology Inc
07/02/202422:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SANASana Biotechnology Inc
07/02/202421:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
07/02/202421:01GlobeNewswire Inc.Sana Biotechnology Announces Proposed Public Offering of Common StockNASDAQ:SANASana Biotechnology Inc
09/01/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
05/01/202414:00GlobeNewswire Inc.Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262, a Hypoimmune-modified, CD22-directed Allogeneic CAR T Therapy, for Patients with Relapsed or Refractory B-cell MalignanciesNASDAQ:SANASana Biotechnology Inc
03/01/202421:05GlobeNewswire Inc.Sana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SANASana Biotechnology Inc
18/12/202321:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SANASana Biotechnology Inc
15/12/202321:34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SANASana Biotechnology Inc
11/12/202321:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
11/12/202314:00GlobeNewswire Inc.Sana Biotechnology Highlights Preclinical Data Supporting Tumor Control and Immune Evasion Capabilities of Hypoimmune-Modified Allogeneic CAR T Cells in Presentations at the American Society of Hematology Annual MeetingNASDAQ:SANASana Biotechnology Inc
01/12/202321:05GlobeNewswire Inc.Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of Intact Immune SystemNASDAQ:SANASana Biotechnology Inc
28/11/202300:01PR Newswire (US)Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science LeadersNASDAQ:SANASana Biotechnology Inc
 Showing the most relevant articles for your search:NASDAQ:SANA

Your Recent History

LSE
NG.
National Grid
LSE
SRSP
Sirius Petroleum
LSE
POS
Plexus
LSE
VAST
Vast Resources
LSE
BIRD
Blackbird
LSE
ENET
Ethernity Networks
LSE
CUSN
Cornish Metals
LSE
SCLP
Scancell
LSE
AVCT
Avacta
LSE
ZED
Zenova
LSE
LLOY
Lloyds Banking
LSE
CHLL
Chill Brands
LSE
BOO
Boohoo
LSE
SAR
Sareum
LSE
GGP
Greatland Gold
LSE
GOLD
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved